» Articles » PMID: 29118900

Effect and Mechanism of Pyrroloquinoline Quinone on Anti-osteoporosis in Bmi-1 Knockout Mice-Anti-oxidant Effect of Pyrroloquinoline Quinone

Overview
Journal Am J Transl Res
Specialty General Medicine
Date 2017 Nov 10
PMID 29118900
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Pyrroloquinoline quinone (PQQ), considered as an ROS scavenger,could protect mitochondrial activity from damage of oxidative stress. To determine the role of PQQ supplement in rescuing long bone osteoporosis in Bmi-1 mice. We fed Bmi-1 knockout mice a diet supplemented with PQQ (BKO+PQQ), BKO mice with normal diet (BKO) and wild type mice with normal diet (WT) as controls. We compared the differences of skeletal phenotype by means of imaging, histopathological and molecular biology methods in three groups of animals. Results showed that BKO+PQQ mice increased morphology of tibia, decreased X-ray transmittance, and increased bone density, thickness of cortical bone, width of growth plate and trabecular bone mass compared with BKO mice. Our study also investigated that, compared mice BKO, PCNA positive cells percentage of tibial growth plate areas significantly increased in BKO+PQQ mice, and TUNEL positive cells percentage was significantly decreased. To detect the effect of PQQ on osteoblast formation of tibiae. Our results showed, compared with BKO mice, osteogenic cell, osteoblast number areas, ALP, Col I and OCN positive areas significantly increased in tibia of BKO+PQQ mice. Further studies showed that supplemental PQQ played a role in anti-osteoporosis by up-regulating antioxidant capacity, inhibiting oxidative stress and reducing DNA damage, down-regulating CDKI proteins levels, and decreasing cell apoptosis. This study not only reveals the mechanism of PQQ supplementation in anti-osteoporosis, but also provides the experimental and theoretical basis for the clinical application of PQQ in osteoporosis.

Citing Articles

Bmi-1 plays an important role in preventing bone aging by regulating the bone microenvironment.

Liu L, Huang Y Int J Clin Exp Pathol. 2025; 17(12):458-468.

PMID: 39802872 PMC: 11711483. DOI: 10.62347/DIIJ2884.


Pyrroloquinoline quinone protects against murine hepatitis virus strain 3-induced fulminant hepatitis by inhibiting the Keap1/Nrf2 signaling.

Pu Z, Ge F, Zhou Y, Liu A, Yang C Cytotechnology. 2024; 76(4):441-452.

PMID: 38933874 PMC: 11196452. DOI: 10.1007/s10616-024-00627-0.


Molecular and Cellular Mechanisms of Osteoporosis.

Zhivodernikov I, Kirichenko T, Markina Y, Postnov A, Markin A Int J Mol Sci. 2023; 24(21).

PMID: 37958752 PMC: 10648156. DOI: 10.3390/ijms242115772.


Chk2 deletion rescues Bmi1 deficiency-induced mandibular osteoporosis by blocking DNA damage response pathway.

Ji X, Chen H, Liu B, Zhuang H, Bu S Am J Transl Res. 2023; 15(3):2220-2232.

PMID: 37056849 PMC: 10086904.


Scutellarin inhibits glioma cell proliferation by up-regulating miR-15a expression.

Du J, Li J, Tan J, Yan Y Am J Transl Res. 2023; 15(3):2156-2163.

PMID: 37056818 PMC: 10086908.


References
1.
Stites T, Mitchell A, Rucker R . Physiological importance of quinoenzymes and the O-quinone family of cofactors. J Nutr. 2000; 130(4):719-27. DOI: 10.1093/jn/130.4.719. View

2.
Bleibler F, Konnopka A, Benzinger P, Rapp K, Konig H . The health burden and costs of incident fractures attributable to osteoporosis from 2010 to 2050 in Germany--a demographic simulation model. Osteoporos Int. 2012; 24(3):835-47. DOI: 10.1007/s00198-012-2020-z. View

3.
Zhu B, Simonis U, Cecchini G, Zhou H, Li L, Teerlink J . Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury. J Cardiovasc Pharmacol Ther. 2006; 11(2):119-28. DOI: 10.1177/1074248406288757. View

4.
Banfi G, Iorio E, Corsi M . Oxidative stress, free radicals and bone remodeling. Clin Chem Lab Med. 2008; 46(11):1550-5. DOI: 10.1515/CCLM.2008.302. View

5.
Zhang H, Ding J, Jin J, Guo J, Liu J, Karaplis A . Defects in mesenchymal stem cell self-renewal and cell fate determination lead to an osteopenic phenotype in Bmi-1 null mice. J Bone Miner Res. 2009; 25(3):640-52. DOI: 10.1359/jbmr.090812. View